Jin X - Search Results

1

Treatment efficacy and safety of adalimumab versus tocilizumab in patients with active and severe Takayasu arteritis: an open-label study.

Wang J, Kong X, Ma L, Ding Z, Chen H, Chen R, Jin X, Chen C, Lin J, Jiang L. Wang J, et al. Among authors: jin x. Rheumatology (Oxford). 2024 May 2;63(5):1359-1367. doi: 10.1093/rheumatology/kead387. Rheumatology (Oxford). 2024. PMID: 37540159 Clinical Trial.

2

Evaluation of clinical measures and different criteria for diagnosis of adult-onset Still's disease in a Chinese population.

Jiang L, Wang Z, Dai X, Jin X. Jiang L, et al. Among authors: jin x. J Rheumatol. 2011 Apr;38(4):741-6. doi: 10.3899/jrheum.100766. Epub 2011 Feb 1. J Rheumatol. 2011. PMID: 21285163

3

Dual-energy computed tomography for monitoring the effect of urate-lowering therapy in gouty arthritis.

Sun Y, Chen H, Zhang Z, Ma L, Zhou J, Zhou Y, Ding Y, Jin X, Jiang L. Sun Y, et al. Among authors: jin x. Int J Rheum Dis. 2015 Nov;18(8):880-5. doi: 10.1111/1756-185X.12634. Epub 2015 Jul 28. Int J Rheum Dis. 2015. PMID: 26217877

4

Cyclophosphamide could be a better choice than methotrexate as induction treatment for patients with more severe Takayasu's arteritis.

Sun Y, Ma L, Ma L, Kong X, Chen H, Lv P, Lin J, Liu H, Yan Y, Ji Z, Yang C, Dai S, Wan W, Zou Y, Jin X, Jiang L. Sun Y, et al. Among authors: jin x. Rheumatol Int. 2017 Dec;37(12):2019-2026. doi: 10.1007/s00296-017-3847-6. Epub 2017 Oct 13. Rheumatol Int. 2017. PMID: 29030659

5

The value of interleukin-6 in predicting disease relapse for Takayasu arteritis during 2-year follow-up.

Sun Y, Kong X, Cui X, Dai X, Ma L, Chen H, Chen R, Lv P, Lin J, Huang Q, Jin X, Jiang L. Sun Y, et al. Among authors: jin x. Clin Rheumatol. 2020 Nov;39(11):3417-3425. doi: 10.1007/s10067-020-05066-8. Epub 2020 May 9. Clin Rheumatol. 2020. PMID: 32388749

6

Pulmonary findings on high-resolution computed tomography in Takayasu arteritis.

Kong X, Zhang J, Lin J, Lv P, Chen H, Ji Z, Dai X, Jin X, Ma L, Jiang L. Kong X, et al. Among authors: jin x. Rheumatology (Oxford). 2021 Dec 1;60(12):5659-5667. doi: 10.1093/rheumatology/keab163. Rheumatology (Oxford). 2021. PMID: 33590834

7

Serum complement 3 is a potential biomarker for assessing disease activity in Takayasu arteritis.

Chen R, Ma L, Lv P, Lin J, Li C, Yan Y, Jin X, Dai X, Ji Z, Chen H, Ma L, Sun Y, Jiang L. Chen R, et al. Among authors: jin x. Arthritis Res Ther. 2021 Feb 24;23(1):63. doi: 10.1186/s13075-021-02433-x. Arthritis Res Ther. 2021. PMID: 33627173 Free PMC article.

8

A novel model to assess disease activity in Takayasu arteritis based on 18F-FDG-PET/CT: a Chinese cohort study.

Ma LY, Wu B, Jin XJ, Sun Y, Kong XF, Ji ZF, Chen RY, Cui XM, Shi HC, Jiang LD. Ma LY, et al. Rheumatology (Oxford). 2022 Apr 18;61(SI):SI14-SI22. doi: 10.1093/rheumatology/keab487. Rheumatology (Oxford). 2022. PMID: 34156465

9

Treatment efficacy and safety of tofacitinib versus methotrexate in Takayasu arteritis: a prospective observational study.

Kong X, Sun Y, Dai X, Wang L, Ji Z, Chen H, Jin X, Ma L, Jiang L. Kong X, et al. Among authors: jin x. Ann Rheum Dis. 2022 Jan;81(1):117-123. doi: 10.1136/annrheumdis-2021-220832. Epub 2021 Aug 6. Ann Rheum Dis. 2022. PMID: 34362744

10

Efficacy and safety of tofacitinib versus leflunomide with glucocorticoids treatment in Takayasu arteritis: A prospective study.

Wang J, Dai X, Ma L, Wu S, Jin X, Ji Z, Chen H, Ma L, Ding Z, Jiang L, Kong X. Wang J, et al. Among authors: jin x. Semin Arthritis Rheum. 2022 Aug;55:152018. doi: 10.1016/j.semarthrit.2022.152018. Epub 2022 Apr 29. Semin Arthritis Rheum. 2022. PMID: 35523066

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13,625 results

Search Page

Filters